These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9208266)

  • 21. The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain-Barré syndrome from chronic inflammatory demyelinating polyneuropathy.
    Sainaghi PP; Collimedaglia L; Alciato F; Leone MA; Naldi P; Molinari R; Monaco F; Avanzi GC
    Cytokine; 2010 Aug; 51(2):138-43. PubMed ID: 20538476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Changes in cerebrospinal fluid immunoglobulin serial parameters in neurologic disorders].
    Wang WZ; Zhou YK
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Feb; 22(1):12-6, 61. PubMed ID: 2805971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features.
    Albers JW; Kelly JJ
    Muscle Nerve; 1989 Jun; 12(6):435-51. PubMed ID: 2657418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoreactive myelin basic protein in cerebrospinal fluid of patients with peripheral neuropathies.
    Cornblath DR; Griffin JW; Tennekoon GI
    Ann Neurol; 1986 Sep; 20(3):370-2. PubMed ID: 2429614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of IgA in the cerebrospinal fluid of neurological patients with special reference to size, subclass and local production.
    Sindic CJ; Delacroix DL; Vaerman JP; Laterre EC; Masson PL
    J Neuroimmunol; 1984 Dec; 7(2-3):65-75. PubMed ID: 6096399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid lipidomic biomarker signatures of demyelination for multiple sclerosis and Guillain-Barré syndrome.
    Péter M; Török W; Petrovics-Balog A; Vígh L; Vécsei L; Balogh G
    Sci Rep; 2020 Oct; 10(1):18380. PubMed ID: 33110173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Enzyme activity of the cerebrospinal fluid in pathological processes of the central nervous system].
    Gromashevskaia LL; Gebesh VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971; 71(7):991-1000. PubMed ID: 4332538
    [No Abstract]   [Full Text] [Related]  

  • 28. [Beta-glucuronidase activity of the cerebrospinal fluid of patients with brain tumors].
    Promyslov MSh; Levchenko LI; Volynkin NM; Makhmudov UG
    Vopr Neirokhir; 1969; 33(4):37-9. PubMed ID: 4312246
    [No Abstract]   [Full Text] [Related]  

  • 29. Autoantibodies to brain specific proteins in human serum from normal and several pathological conditions.
    Melse J; Noppe M; Crols R; Gheuens J; Lowenthal A
    Acta Neurol Belg; 1983; 83(1):17-22. PubMed ID: 6305087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytology of neoplastic meningosis.
    Kölmel HW
    J Neurooncol; 1998; 38(2-3):121-5. PubMed ID: 9696361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Central nervous system damage in inflammatory demyelinating polyneuropathies].
    Ponomarev VV; Antonov IP; Antonenko AI; Ovsiankina GI; Khodulev VI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(11):17-9. PubMed ID: 12497990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical usefulness of oligoclonal bands].
    Falip M; Tintoré M; Jardí R; Duran I; Link H; Montalbán X
    Rev Neurol; 2001 Jun 16-30; 32(12):1120-4. PubMed ID: 11562840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preliminary study on immunoglobulins G in the cerebrospinal fluid of neurological patients].
    Cognazzo A; Grasso E
    Minerva Med; 1977 May; 68(22):1531-5. PubMed ID: 870857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Examination of the cerebrospinal fluid in supratentorial cerebral tumors. Statistical findings and practical considerations].
    Majeron MA
    Minerva Med; 1969 Jun; 60(50):2500-2. PubMed ID: 4307283
    [No Abstract]   [Full Text] [Related]  

  • 35. Isolated blood-cerebrospinal fluid barrier dysfunction: prevalence and associated diseases.
    Brettschneider J; Claus A; Kassubek J; Tumani H
    J Neurol; 2005 Sep; 252(9):1067-73. PubMed ID: 15789126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Myelin diseases affecting both the central and the peripheral nervous system].
    Hagen K; Mellgren SI; Bovim G
    Tidsskr Nor Laegeforen; 1998 Sep; 118(23):3600-2. PubMed ID: 9820004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The immunosorption of the cerebrospinal fluid in the treatment of inflammatory demyelinating polyneuropathies].
    Ponomarev VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(6):27-8. PubMed ID: 10441863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal fluid and serum light polypeptide chains in 160 patients with various nervous system disorders.
    Kolar O; Anthony E
    Z Neurol; 1971; 200(1):6-17. PubMed ID: 4107209
    [No Abstract]   [Full Text] [Related]  

  • 39. In vivo estimation of water content in cerebral white matter of brain tumour patients and normal individuals: towards a quantitative brain oedema definition.
    Andersen C
    Acta Neurochir (Wien); 1997; 139(3):249-55; discussion 255-6. PubMed ID: 9143593
    [No Abstract]   [Full Text] [Related]  

  • 40. The relative diagnostic sensitivity of different F-wave parameters in various polyneuropathies.
    Fraser JL; Olney RK
    Muscle Nerve; 1992 Aug; 15(8):912-8. PubMed ID: 1495506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.